AR068038A1 - Polipeptidos de la hormona de crecimiento modificada - Google Patents
Polipeptidos de la hormona de crecimiento modificadaInfo
- Publication number
- AR068038A1 AR068038A1 ARP080103700A ARP080103700A AR068038A1 AR 068038 A1 AR068038 A1 AR 068038A1 AR P080103700 A ARP080103700 A AR P080103700A AR P080103700 A ARP080103700 A AR P080103700A AR 068038 A1 AR068038 A1 AR 068038A1
- Authority
- AR
- Argentina
- Prior art keywords
- growth hormone
- polypeptides
- modified growth
- proteins
- fusion proteins
- Prior art date
Links
- 102000018997 Growth Hormone Human genes 0.000 title abstract 3
- 108010051696 Growth Hormone Proteins 0.000 title abstract 3
- 239000000122 growth hormone Substances 0.000 title abstract 3
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 102000037865 fusion proteins Human genes 0.000 abstract 2
- 108020001507 fusion proteins Proteins 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 239000000539 dimer Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US97901007P | 2007-10-10 | 2007-10-10 | |
| GBGB0719818.7A GB0719818D0 (en) | 2007-10-11 | 2007-10-11 | Growth hormone fusion polypeptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR068038A1 true AR068038A1 (es) | 2009-10-28 |
Family
ID=38787949
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP080103700A AR068038A1 (es) | 2007-10-10 | 2008-08-26 | Polipeptidos de la hormona de crecimiento modificada |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US8273552B2 (enExample) |
| EP (2) | EP2886553A1 (enExample) |
| JP (1) | JP5697983B2 (enExample) |
| KR (1) | KR20100067686A (enExample) |
| CN (1) | CN101932600B (enExample) |
| AR (1) | AR068038A1 (enExample) |
| AU (1) | AU2008309386A1 (enExample) |
| BR (1) | BRPI0818639A2 (enExample) |
| CA (1) | CA2701369A1 (enExample) |
| DK (1) | DK2209798T3 (enExample) |
| ES (1) | ES2532600T3 (enExample) |
| GB (1) | GB0719818D0 (enExample) |
| IL (1) | IL203073A0 (enExample) |
| MX (1) | MX2010003892A (enExample) |
| RU (1) | RU2471808C2 (enExample) |
| TW (1) | TW200918098A (enExample) |
| WO (1) | WO2009047474A2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0606946D0 (en) * | 2006-04-06 | 2006-05-17 | Asterion Ltd | Polypeptide antagonist |
| GB201104285D0 (en) * | 2011-03-15 | 2011-04-27 | Asterion Ltd | Modified receptor fusion proteins |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH20A (fr) * | 1888-12-05 | Joseph Magnat | Une pompe à bière automatique fonctionnant par la pression de l'eau | |
| DE851925T1 (de) * | 1995-09-21 | 2003-08-14 | Genentech Inc., San Francisco | Varianten des menschlichen wachstumshormons |
| GB0018891D0 (en) * | 2000-08-01 | 2000-09-20 | Novartis Ag | Organic compounds |
| EP1290170A2 (en) * | 2000-06-16 | 2003-03-12 | Asterion Limited | Binding agents: chimeric ligand/receptor proteins |
| EP1456398B1 (en) * | 2001-11-21 | 2011-05-11 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Recovery of recombinant human parainfluenza virus type 1 (hpivi) from cdna |
| GB2389115B (en) * | 2001-12-14 | 2005-03-16 | Asterion Ltd | Polypeptide having a plurality of modified growth hormone receptor binding domains of growth hormone |
| US7625998B2 (en) * | 2003-04-09 | 2009-12-01 | Asterion Limited | Cytokine polypeptides and antibodies containing a signal sequence for the attachment of glycosylphosphatidylinositol |
| US20090221477A1 (en) * | 2004-07-26 | 2009-09-03 | Asterion Limited | Linkers |
| GB0717985D0 (en) * | 2007-07-20 | 2007-10-24 | Asterion Ltd | Growth hormone fusion proteins |
| JP2011512134A (ja) * | 2008-02-19 | 2011-04-21 | アステリオン・リミテッド | 修飾リンカー |
-
2007
- 2007-10-11 GB GBGB0719818.7A patent/GB0719818D0/en not_active Ceased
-
2008
- 2008-08-20 TW TW097131758A patent/TW200918098A/zh unknown
- 2008-08-26 AR ARP080103700A patent/AR068038A1/es not_active Application Discontinuation
- 2008-09-10 EP EP14197613.4A patent/EP2886553A1/en not_active Withdrawn
- 2008-09-10 WO PCT/GB2008/003056 patent/WO2009047474A2/en not_active Ceased
- 2008-09-10 CN CN200880106595.1A patent/CN101932600B/zh not_active Expired - Fee Related
- 2008-09-10 BR BRPI0818639 patent/BRPI0818639A2/pt not_active Application Discontinuation
- 2008-09-10 KR KR1020107010215A patent/KR20100067686A/ko not_active Ceased
- 2008-09-10 ES ES08788565.3T patent/ES2532600T3/es active Active
- 2008-09-10 MX MX2010003892A patent/MX2010003892A/es not_active Application Discontinuation
- 2008-09-10 EP EP08788565.3A patent/EP2209798B1/en not_active Not-in-force
- 2008-09-10 DK DK08788565T patent/DK2209798T3/en active
- 2008-09-10 AU AU2008309386A patent/AU2008309386A1/en not_active Abandoned
- 2008-09-10 JP JP2010528468A patent/JP5697983B2/ja not_active Expired - Fee Related
- 2008-09-10 CA CA2701369A patent/CA2701369A1/en not_active Abandoned
- 2008-09-10 US US12/678,282 patent/US8273552B2/en not_active Expired - Fee Related
- 2008-09-10 RU RU2010103159/10A patent/RU2471808C2/ru not_active IP Right Cessation
-
2009
- 2009-12-31 IL IL203073A patent/IL203073A0/en unknown
-
2012
- 2012-08-22 US US13/592,252 patent/US20120322735A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| RU2471808C2 (ru) | 2013-01-10 |
| RU2010103159A (ru) | 2011-11-20 |
| EP2886553A1 (en) | 2015-06-24 |
| US20120322735A1 (en) | 2012-12-20 |
| KR20100067686A (ko) | 2010-06-21 |
| TW200918098A (en) | 2009-05-01 |
| WO2009047474A2 (en) | 2009-04-16 |
| MX2010003892A (es) | 2010-05-17 |
| GB0719818D0 (en) | 2007-11-21 |
| DK2209798T3 (en) | 2015-03-23 |
| EP2209798B1 (en) | 2014-12-31 |
| ES2532600T3 (es) | 2015-03-30 |
| CN101932600B (zh) | 2014-05-28 |
| IL203073A0 (en) | 2010-11-30 |
| EP2209798A2 (en) | 2010-07-28 |
| BRPI0818639A2 (pt) | 2015-04-07 |
| WO2009047474A3 (en) | 2010-09-02 |
| JP5697983B2 (ja) | 2015-04-08 |
| CA2701369A1 (en) | 2009-04-16 |
| CN101932600A (zh) | 2010-12-29 |
| AU2008309386A1 (en) | 2009-04-16 |
| JP2011507487A (ja) | 2011-03-10 |
| US8273552B2 (en) | 2012-09-25 |
| US20100197589A1 (en) | 2010-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1124697T1 (el) | Πρωτεϊνες συντηξης για τη θεραπεια διαταραχων του μεταβολισμου | |
| UA113609C2 (xx) | Антигензв'язуючий білок, який зв'язує людський il-23 | |
| UY33826A (es) | Proteínas de unión con dominios trivariables y sus usos | |
| EA201170242A1 (ru) | Модифицированные бычьи полипептиды g-csf и их применение | |
| PH12019500596B1 (en) | Recombinant binding proteins and their use | |
| EA201171148A1 (ru) | Антитело-антагонист, специфичное для гетеродимера альфа-4-бета-7 | |
| AU2016240220B2 (en) | Designed ankyrin repeat domains with binding specificity for serum albumin | |
| SG10201808523RA (en) | Il-22 polypeptides and il-22 fc fusion proteins and methods of use | |
| MY206284A (en) | Anti-cd63 antibodies, conjugates, and uses thereof | |
| EA201400993A1 (ru) | Антитела против рецептора эпидермального фактора роста, активные в определенных условиях, и способы их применения | |
| CL2008001675A1 (es) | Dominio variable simple (dab) de inmunoglobulina anti-factorde crecimiento endotelial vascular (vegf); acido nucleico que lo codifica; vector y celula huesped; metodo de produccion;antogonista de vegf que comprende el dab; composicion que comprende antogonista;y uso del antagonista para preparar un medicamento. | |
| MX2024005945A (es) | Polipeptidos que se unen al componente del complemento c5 o albumina serica y proteinas de fusion de los mismos. | |
| EA201001204A1 (ru) | Методы и композиции, в которых применяют слитые полипептиды klotho-fgf | |
| PH12016500081B1 (en) | Immunoglobulin variants and uses thereof | |
| ECSP12011885A (es) | Inmunoglobulinas con dominio variable dual | |
| MX388739B (es) | Casetes optimizados de expresión del gen humano del factor viii de coagulación y su uso. | |
| EA202090216A2 (ru) | Связывающие сывороточный альбумин домены фибронектина iii типа | |
| JO3182B1 (ar) | مضادات حيوية بشرية عالية الالفة مع تولد الاوعية البشرية - 2 | |
| CL2012001504A1 (es) | Proteinas de enlace a antigenos humanas porque induce la sensibilizacion mediada por factor 21 de crecimiento de fibroblastos (fgf21); acido nucleico que lo codifica; vector y celula aislada que comprenden el acido nucleico; metodo de produccion de dicha proteina. | |
| CR11795A (es) | Inmunoglobulinas con dominio variable dual y usos de las mismas | |
| EA201500172A1 (ru) | Модифицированные полипептиды фактора х и их применение | |
| AR113492A2 (es) | Furina recombinante libre de proteínas sustancialmente animal y métodos para producirla | |
| WO2009013461A8 (en) | Growth hormone fusion proteins | |
| AR095418A1 (es) | Métodos para aumentar el contenido de manosa en proteínas recombinantes | |
| MX2011004483A (es) | Leucolectinas y sus usos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |